Douglas Mike Day Psychedelic Therapy to Save Lives Act of 2023

HR 3684, the Douglas Mike Day Psychedelic Therapy to Save Lives Act of 2023, authorizes the Department of Defense to fund research on using psychedelic substances for treating specific conditions in active-duty military personnel. The bill creates a grant program to support phase II clinical trials (using substances like MDMA, psilocybin, or ibogaine) or training for treating PTSD, traumatic brain injury, or chronic traumatic encephalopathy, with participants including active-duty service members. It removes barriers for military personnel to join these trials, regardless of federal scheduling of the substances or military justice rules. The bill appropriates $15 million annually from 2024 to 2028 for this research and requires regular reports to Congress on grant recipients and trial findings.